Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-16

Clinical Trial Update: Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety and pharmacokinetics of nitrite for prevention of cerebral vasospasm following subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrite (nitrite)

Snippet

Sponsor: Hope Pharmaceuticals | Conditions: Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED | Results posted: 2013-07-16